CN102041265A - 检测甲型h1n1病毒抗原的免疫检测试剂 - Google Patents
检测甲型h1n1病毒抗原的免疫检测试剂 Download PDFInfo
- Publication number
- CN102041265A CN102041265A CN 201010501551 CN201010501551A CN102041265A CN 102041265 A CN102041265 A CN 102041265A CN 201010501551 CN201010501551 CN 201010501551 CN 201010501551 A CN201010501551 A CN 201010501551A CN 102041265 A CN102041265 A CN 102041265A
- Authority
- CN
- China
- Prior art keywords
- influenza
- virus
- h1n1virus
- antigenic
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 25
- 239000000427 antigen Substances 0.000 title abstract description 17
- 102000036639 antigens Human genes 0.000 title abstract description 17
- 108091007433 antigens Proteins 0.000 title abstract description 17
- 208000037797 influenza A Diseases 0.000 title abstract description 9
- 238000003018 immunoassay Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000013604 expression vector Substances 0.000 claims abstract description 8
- 238000003259 recombinant expression Methods 0.000 claims abstract description 8
- 238000012360 testing method Methods 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 19
- 230000000890 antigenic effect Effects 0.000 claims description 18
- 238000011238 DNA vaccination Methods 0.000 claims description 12
- 210000004408 hybridoma Anatomy 0.000 claims description 12
- 230000036737 immune function Effects 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 7
- 101710186708 Agglutinin Proteins 0.000 claims description 3
- 108010017384 Blood Proteins Proteins 0.000 claims description 3
- 101710146024 Horcolin Proteins 0.000 claims description 3
- 101710189395 Lectin Proteins 0.000 claims description 3
- 101710179758 Mannose-specific lectin Proteins 0.000 claims description 3
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims description 3
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000000910 agglutinin Substances 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 abstract description 14
- 230000003053 immunization Effects 0.000 abstract description 11
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 239000013612 plasmid Substances 0.000 abstract description 6
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 101710154606 Hemagglutinin Proteins 0.000 abstract description 4
- 101710093908 Outer capsid protein VP4 Proteins 0.000 abstract description 4
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 abstract description 4
- 101710176177 Protein A56 Proteins 0.000 abstract description 4
- 230000001900 immune effect Effects 0.000 abstract description 4
- 239000000185 hemagglutinin Substances 0.000 abstract description 3
- 102000053602 DNA Human genes 0.000 abstract 3
- 108010041986 DNA Vaccines Proteins 0.000 abstract 3
- 229940021995 DNA vaccine Drugs 0.000 abstract 3
- 101150039660 HA gene Proteins 0.000 abstract 2
- 108010056741 H1N1 virus hemagglutinin Proteins 0.000 abstract 1
- 239000013600 plasmid vector Substances 0.000 abstract 1
- 241000700605 Viruses Species 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 10
- 238000012216 screening Methods 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 238000002649 immunization Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 7
- 229960005486 vaccine Drugs 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 5
- 239000012980 RPMI-1640 medium Substances 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 241000710914 Totivirus Species 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229940023146 nucleic acid vaccine Drugs 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 210000003314 quadriceps muscle Anatomy 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 238000003805 vibration mixing Methods 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101710116034 Immunity protein Proteins 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000002303 anti-venom Effects 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000024835 cytogamy Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 108700010900 influenza virus proteins Proteins 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
克隆号 | 亚类 |
2B1 | IgG2a |
3G4 | IgG1 |
稀释滴度 | 1∶3200 | 1∶6400 | 1∶12800 | 1∶25600 | 1∶51200 | 1∶10万 | 1∶20万 | 阴性 |
OD值 | 0.83 | 0.63 | 0.31 | 0.15 | 0.15 | 0.10 | 0.08 | 0.05 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010501551A CN102041265B (zh) | 2010-09-30 | 2010-09-30 | 检测甲型h1n1病毒抗原的免疫检测试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010501551A CN102041265B (zh) | 2010-09-30 | 2010-09-30 | 检测甲型h1n1病毒抗原的免疫检测试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102041265A true CN102041265A (zh) | 2011-05-04 |
CN102041265B CN102041265B (zh) | 2012-10-17 |
Family
ID=43907813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010501551A Active CN102041265B (zh) | 2010-09-30 | 2010-09-30 | 检测甲型h1n1病毒抗原的免疫检测试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102041265B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106771181A (zh) * | 2016-11-24 | 2017-05-31 | 剑药(苏州)生物技术有限公司 | 一种禽流感h7n9血凝素ha抗原检测 elisa 试剂盒及检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092456A (zh) * | 2007-06-15 | 2007-12-26 | 中国疾病预防控制中心病毒病预防控制所 | 人源中和性抗禽流感病毒h5n1基因工程抗体 |
CN101541832A (zh) * | 2006-09-07 | 2009-09-23 | 克鲁塞尔荷兰公司 | 能中和流感病毒h5n1的人结合分子及其应用 |
-
2010
- 2010-09-30 CN CN201010501551A patent/CN102041265B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101541832A (zh) * | 2006-09-07 | 2009-09-23 | 克鲁塞尔荷兰公司 | 能中和流感病毒h5n1的人结合分子及其应用 |
CN101092456A (zh) * | 2007-06-15 | 2007-12-26 | 中国疾病预防控制中心病毒病预防控制所 | 人源中和性抗禽流感病毒h5n1基因工程抗体 |
Non-Patent Citations (2)
Title |
---|
《GenBank》 20090618 Ye Z等 GenBank:GQ280797.1 1-3,6 , 2 * |
《PLoS One》 20100505 Steitz J等 A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice e10492 1-3,6 第5卷, 第5期 2 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106771181A (zh) * | 2016-11-24 | 2017-05-31 | 剑药(苏州)生物技术有限公司 | 一种禽流感h7n9血凝素ha抗原检测 elisa 试剂盒及检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102041265B (zh) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111153991A (zh) | 一种人SARS-CoV-2单克隆抗体及其制备方法和应用 | |
CN101825633B (zh) | 用于检测非洲猪瘟病毒的竞争elisa试剂盒 | |
EP0279563B1 (en) | Influenza vaccine | |
CN102747044B (zh) | 一种抗猪伪狂犬病病毒的杂交瘤细胞系及其制备方法和一种单克隆抗体及其应用 | |
NZ197553A (en) | Production of antigens specific to r.s.v.;cell lines bearing these antigens and pharmaceutical compositions | |
CN102731615A (zh) | Prrsv的检测试剂和检测方法 | |
CN105859842B (zh) | A型口蹄疫病毒单克隆抗体识别的中和表位及其应用 | |
CN104826098B (zh) | 一种a型口蹄疫标记疫苗及其构建方法 | |
CN116699127A (zh) | 用于结核菌素效价标定的试剂盒、标定方法及其应用 | |
Hinuma et al. | Studies on the Complement-Fixing Antigens of Poliomyelitis: III. Intracellular Development of Antigen | |
CN113024666B (zh) | 具有广谱性识别a型流感病毒np蛋白的单克隆抗体及其应用 | |
CN105348372A (zh) | 一种猪伪狂犬病毒的检测方法 | |
CN108752471A (zh) | 抗pcv2单克隆抗体的制备方法及其应用 | |
CN101082626A (zh) | 检测Asial型口蹄疫病毒的ELISA试剂盒及制备方法 | |
CN102041265B (zh) | 检测甲型h1n1病毒抗原的免疫检测试剂 | |
CN105504051B (zh) | 狂犬病毒核蛋白单克隆抗体及其应用 | |
CN104965083B (zh) | 一种检测h3n2亚型犬流感病毒的试剂盒 | |
CN107586783A (zh) | 抗小反刍兽疫病毒n蛋白单克隆抗体及其应用 | |
CN110527668A (zh) | 一种抗弓形虫棒状体蛋白4(rop4)单克隆抗体及其制备方法与应用 | |
CN109374886A (zh) | 牛传染性鼻气管炎病毒抗体检测试剂盒及其应用 | |
CN115960220A (zh) | 特异性结合柯萨奇病毒a6的单克隆抗体及其用途 | |
CN105259347B (zh) | 一种肠道病毒71的检测方法及其试剂盒 | |
CN111073859B (zh) | 一种检测牛细小病毒的双抗体夹心elisa试剂盒及其应用 | |
CN110484511B (zh) | 杂交瘤细胞株、其分泌的识别盖他病毒单克隆抗体及应用 | |
CN114316037A (zh) | 一种O型口蹄疫病毒结构蛋白的抗体m19、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170302 Address after: 430000 East Lake high tech Development Zone, Wuhan Province, high and new avenue, No. 666 (Wuhan Institute of biotechnology, building B7, building 2, B102) Patentee after: Wuhan Kerui Hao Technology Development Co.,Ltd. Address before: 430071 Wuchang District, Hubei, Hongshan small Central District No. 44, No. Patentee before: Wuhan Institute of Virology, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170503 Address after: 430000 No. 2, building 21, building 76, building 118, 1 Qin Lu Yuan, Wuchang District, Hubei, Wuhan Patentee after: Yan Bing Address before: 430000 East Lake high tech Development Zone, Wuhan Province, high and new avenue, No. 666 (Wuhan Institute of biotechnology, building B7, building 2, B102) Patentee before: Wuhan Kerui Hao Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170531 Address after: 2 B301-313, building 430000, building B7, 666 hi tech Avenue, East Lake Development Zone, Wuhan, Hubei, Wuhan Patentee after: Wuhan Keyuan Bo Biological Technology Co.,Ltd. Address before: 430000 No. 2, building 21, building 76, building 118, 1 Qin Lu Yuan, Wuchang District, Hubei, Wuhan Patentee before: Yan Bing |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230627 Address after: 430071 No.44, Xiaohongshan Middle District, guoguohu street, Wuchang District, Wuhan City, Hubei Province Patentee after: Wuhan Institute of Virology, Chinese Academy of Sciences Address before: B301-313, 2 / F, B7 building, Biotechnology Research Institute, 666 Gaoxin Avenue, Wuhan East Lake Development Zone, Wuhan City, Hubei Province, 430000 Patentee before: Wuhan Keyuan Bo Biological Technology Co.,Ltd. |